Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNLAE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,136
Award facts
- Contract value 100% obligated
- $19,135.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,135.68 to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors on September 24, 2025, with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. DUPIXENT (dupilumab) is a biologic immunosuppressant medication commonly prescribed for eczema, asthma, and other inflammatory conditions, making this order part of the Defense Logistics Agency's medical supply procurement to support military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp regularly supplies brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems through the Defense Health Agency and other government healthcare organizations. The firm's extensive contract history with the Defense Logistics Agency demonstrates its capability to fulfill federal pharmaceutical procurement requirements through open competition across multiple therapeutic domains and delivery scales.
Quick answers
Who was awarded contract SPE2DB25FNLAE?
SPE2DB25FNLAE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FNLAE worth?
The government has obligated $19,136 on SPE2DB25FNLAE.
Is contract SPE2DB25FNLAE an order under another contract?
Yes. SPE2DB25FNLAE is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNLAE competed?
The extent of competition for SPE2DB25FNLAE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award